Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Verrica Pharmaceuticals Inc maintains a gross margin of 92.27%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.34%, while the net margin is -1.91%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively VRCA converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, VRCA competes directly with industry leaders such as TTRX and INO. With a market capitalization of $110.49M, it holds a significant position in the sector. When comparing efficiency, VRCA's gross margin of 92.27% stands against TTRX's N/A and INO's 100.00%. Such benchmarking helps identify whether Verrica Pharmaceuticals Inc is trading at a premium or discount relative to its financial performance.
